Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Euronext Paris  >  BioAlliance Pharma SA    C4X   

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (€)
Sales 2015 6,97 M
EBIT 2015 -16,3 M
Net income 2015 -17,4 M
Debt 2015 13,5 M
Yield 2015 -
Sales 2016 18,4 M
EBIT 2016 -11,1 M
Net income 2016 -12,4 M
Debt 2016 13,3 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 23,9x
EV / Sales 2016 9,05x
Capitalization 153 M
More Financials
Company
Onxeo SA engages in the development of drugs for the treatment of cancer.The firm produces and develops ophan oncology products under the brand names Livatag, Validive, Beleodaq, and AMEP.It also offers specialty products under the brand names Loramyc/Oravig, Sitavig, and Fluriad.The company was... 
Sector
Pharmaceuticals
Calendar
09/16 | 05:30amEarnings Call
More about the company
Surperformance© ratings of BioAlliance Pharma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOALLIANCE PHARMA SA
09/01 ONXEO : Capital Increase in Onxeo Resulting from the Exercise of Share Subscript..
08/31 ONXEO : Capital increase in Onxeo resulting from the exercise of share subscript..
08/06 ONXEO : Disclosure of Total Number of Voting Rights and Number of Shares in the ..
08/06 ONXEO : Disclosure of Total Number of Voting Rights and Number of Shares in the ..
08/05 ONXEO : Patent Issued for Treating Inflammation and Inflammatory Pain in Mucosa ..
07/31 ONXEO : Reports First Half 2015 Business Update and Consolidated Accounts
07/30 ONXEO : Reports First Half 2015 Business Update and Consolidated Accounts &ndash..
07/22 ONXEO : Update on ReLive, Livatag® International Phase III Clinical Trial in HCC
More news
Sector news : Pharmaceuticals - NEC
05:33p Lannett to buy UCB's U.S. speciality generic drugs unit for $1.23 billion
04:16pDJNovartis Closer to Selling Copy of Amgen's Neupogen
04:16p BRISTOL MYERS SQUIBB : to Present New Data from its Immuno-Oncology Clinical Dev..
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions